Skip to main content
    S

    Shattuck Labs Inc (STTK)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $4.66
    +0.01 (+0.22%)

    Market Cap: $473.57M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Shattuck Labs Inc (STTK) Stock Forecast

    Updated Nov 17, 2026. Estimates and ratings come from consensus analyst data.

    Analysts expect Shattuck Labs (STTK) to earn -$0.55 per share in the fiscal year ending Dec 31, 2026, on revenue of $122220. Of 12 analysts, 12 rate the stock Buy or Strong Buy, 0 Hold and 0 Sell or Strong Sell, for a consensus of Buy. Over the last 30 days, 1 estimate for the fiscal year ending Dec 31, 2026 was revised up and 5 down.

    Analyst Ratings

    Scoring Strong Buy as 1 and Strong Sell as 5, the 12 ratings average 1.75, inside the Buy band from 1.5 up to 2.5. Buy and Strong Buy make up 100% of the ratings.

    RatingAnalystsShare
    Strong Buy325.0%
    Buy975.0%
    Hold00.0%
    Sell00.0%
    Strong Sell00.0%
    Consensus
    Buy
    Total analysts
    12

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Annual Estimates

    From the first fiscal year below to the second, the EPS consensus shows a larger loss and revenue estimates are unchanged.

    Fiscal year ending Dec 31, 2026
    -$0.55
    EPS consensus, revenue $122220
    Fiscal year ending Dec 31, 2027
    -$0.58
    EPS consensus, revenue $122220
    Next report
    Mar 3, 2027
    Estimated

    EPS range

    Fiscal year endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Dec 31, 2026-$0.55-$1.13 to -$0.4011$122220N/A9
    Dec 31, 2027-$0.58-$1.14 to -$0.3711$122220N/A9

    Quarterly Estimates

    The EPS consensus rises from -$0.15 for the quarter ending Dec 31, 2026 to -$0.14 for the quarter ending Mar 31, 2027.

    EPS range

    Quarter endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Dec 31, 2026-$0.15-$0.25 to -$0.1113$160283N/A10
    Mar 31, 2027-$0.14-$0.15 to -$0.125$60000N/A5

    Estimate Revisions

    Across the 3 periods below, the last 30 days brought 2 upward and 10 downward EPS revisions. Cuts outnumber raises in every period.

    PeriodUp 30 daysDown 30 days
    Fiscal year ending Dec 31, 202615
    Fiscal year ending Dec 31, 202714
    Quarter ending Mar 31, 202701

    EPS Trend

    Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has worsened from -$0.41.

    PeriodNow7 days ago30 days ago60 days ago90 days agoChange
    Fiscal year ending Dec 31, 2026-$0.55-$0.48-$0.48-$0.48-$0.41N/A
    Fiscal year ending Dec 31, 2027-$0.58-$0.52-$0.53-$0.52-$0.44N/A
    Quarter ending Mar 31, 2027-$0.14-$0.11-$0.12-$0.12-$0.11N/A

    Frequently Asked Questions About STTK

    What is the STTK stock forecast?

    Consensus analyst estimates put Shattuck Labs's EPS at -$0.55 for the fiscal year ending Dec 31, 2026, on revenue of $122220. The consensus rating from 12 analysts is Buy.

    How do analysts rate STTK stock?

    Of 12 analysts covering Shattuck Labs, 3 rate it Strong Buy, 9 Buy, 0 Hold, 0 Sell and 0 Strong Sell, for a consensus of Buy.

    What EPS do analysts expect from STTK next year?

    For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is -$0.55, with estimates from -$1.13 to -$0.40 from 11 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is -$0.58, with estimates from -$1.14 to -$0.37 from 11 analysts.

    What revenue do analysts expect from Shattuck Labs next year?

    For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $122220. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $122220.

    How many analysts cover STTK?

    12 analysts rate Shattuck Labs stock, and 11 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.